NG Biotech CARBA-5
For rapid detection of Carbapenemases.
Improved range of variants now detected across all ‘big 5’ carbapenemase families for infection prevention and control purposes.
The NG Biotech CARBA 5 detects multiple mechanisms, giving a clearer picture of the problem as a whole, aiding treatment decisions and helping to inform isolation/PPE decisions etc. whilst also assisting in infection control and supporting #antimicrobialstewardship.
NG-Test CARBA 5 aids in the rapid identification of carbapenemase-producing Enterobacterales and Pseudomonas aeruginosa in healthcare settings.
NG-Test CARBA-5 detects one or more of the five common types of carbapenemase enzymes (KPC (K), OXA-48-like (O), IMP (I), VIM (V), NDM (N)) from carbapenem-non-susceptible Gram-negative bacterial colonies.
NG Biotech – AMR Range Brochure – Rapid detection and differentiation of expressed resistance mechanisms (AMR)
NG Biotech – AMR Range – Selection of peer reviewed publications about the NG Tests
Una Health White Paper – Lateral flow testing in an antimicrobial resistance pandemic
UK Health Security Agency Report: Commercial assays for the detection of acquired carbapenemases
Journal of Clinical Microbiology (ASM Journals): Evaluation of NG-Test Carba 5 for Rapid Phenotypic Detection and Differentiation of Five Common Carbapenemase Families: Results of a Multicenter Clinical Evaluation (2020)
Oxford Academic, Journal of Antimicrobial Chemotherapy: Evaluation of the NG-Test CARBA 5 multiplex immunochromatographic assay for the detection of KPC, OXA-48-like, NDM, VIM and IMP carbapenemases (2018)
NG-Test® CARBA-5 from NG Biotech – Operating procedure